ARTICLE | Clinical News
Amitiza lubiprostone regulatory update
February 2, 2015 8:00 AM UTC
Sucampo said Health Canada accepted for review an NDS for oral Amitiza lubiprostone to treat chronic idiopathic constipation (CIC) in adults and opioid-induced constipation (OIC) in adults with chroni...